Datar Cancer Genetics
PrivateLast Round
VC Round
Nov 27, 2024
Company Overview
Datar Cancer Genetics is a molecular oncology company that develops non-invasive diagnostic solutions for cancer, including liquid biopsies for early detection, treatment guidance, and monitoring.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Datar Cancer Genetics Comparables
Compare Datar Cancer Genetics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DiaCarta, Inc. | 82% | |
| CellMax Life | 82% | |
| ClearNote Health | 80% |
Datar Cancer Genetics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 27, 2024 | ||||
| Series A | Aug 26, 2024 |
Datar Cancer Genetics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alkemi Growth Capital | VC Round, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 23, 2025
Launched NaturaGene-AI, an advanced oncology testing panel.
- Feb 11, 2025
Dr. Massimo Cristofanilli appointed as Strategic Advisor.
Datar Cancer Genetics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Datar Cancer Genetics's valuation, stock price, and market status.
Is Datar Cancer Genetics a public or private company?
Datar Cancer Genetics is a private company.
What is the current stock price of Datar Cancer Genetics?
Datar Cancer Genetics is a private company with no public stock price. No recent secondary market data is available.
How much is Datar Cancer Genetics worth (valuation)?
Valuation information for Datar Cancer Genetics is not publicly available.
Can I buy Datar Cancer Genetics stock?
Datar Cancer Genetics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Datar Cancer Genetics's last funding round?
Datar Cancer Genetics's most recent funding round was VC Round on November 27, 2024.
Who are the main investors in Datar Cancer Genetics?
Key investors in Datar Cancer Genetics include Alkemi Growth Capital.
Will Datar Cancer Genetics IPO soon?
No public IPO plans have been announced for Datar Cancer Genetics.
How can I track Datar Cancer Genetics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Datar Cancer Genetics's secondary market activity and sign up for updates.